NFJ Investment Group’s ConocoPhillips COP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Sell
8,610
-5,182
-38% -$574K 0.04% 178
2025
Q4
$1.29M Sell
13,792
-1
-0% -$90 0.05% 180
2025
Q3
$1.3M Sell
13,793
-129
-0.9% -$12.2K 0.04% 208
2025
Q2
$1.25M Sell
13,922
-133
-0.9% -$12K 0.04% 236
2025
Q1
$1.48M Buy
14,055
+2,565
+22% +$256K 0.05% 221
2024
Q4
$1.14M Sell
11,490
-114
-1% -$12.1K 0.04% 243
2024
Q3
$1.22M Sell
11,604
-170
-1% -$18.7K 0.04% 242
2024
Q2
$1.35M Sell
11,774
-145
-1% -$17.6K 0.04% 216
2024
Q1
$1.52M Buy
+11,919
New +$1.36M 0.04% 203
2022
Q2
Sell
-99,460
Closed -$9.95M 322
2022
Q1
$9.95M Sell
99,460
-1,635
-2% -$150K 0.2% 154
2021
Q4
$7.3M Sell
101,095
-5,040
-5% -$367K 0.13% 181
2021
Q3
$7.19M Sell
106,135
-2,413
-2% -$139K 0.14% 175
2021
Q2
$6.61M Sell
108,548
-10,354
-9% -$577K 0.13% 194
2021
Q1
$6.3M Buy
+118,902
New +$5.86M 0.13% 206

Other funds holding COP

NFJ Investment Group's COP Position: Q1 2026 in Review

NFJ Investment Group reduced its ConocoPhillips (COP) stake by 38% in Q1 2026, selling an estimated $574K and leaving 8,610 shares worth $1.14M. The position accounts for 0.04% of the portfolio, ranked #178.

NFJ Investment Group first reported a position in COP in Q1 2021 and has held it in 14 quarters since. The position peaked at $9.95M in Q1 2022. 2,560 funds tracked by Wall St. Rank hold COP as of Q1 2026.

  • NFJ Investment Group held 8,610 shares of ConocoPhillips worth $1.14M as of Q1 2026.
  • NFJ Investment Group sold 5,182 ConocoPhillips shares in Q1 2026, an estimated $574K.
  • ConocoPhillips made up 0.04% of NFJ Investment Group's portfolio in Q1 2026, its #178 holding.
  • NFJ Investment Group first reported a position in ConocoPhillips in Q1 2021 and has held it in 14 quarters since.
  • NFJ Investment Group's ConocoPhillips position peaked at $9.95M in Q1 2022.
  • 2,560 funds tracked by Wall St. Rank held ConocoPhillips as of Q1 2026.

Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.